ACS 2010

Recent articles

Uncharted territory

Drug companies have been curiously reluctant to dive into research on therapies for autism. The chief of Pfizer's new autism research unit explains why.

By Deborah Rudacille
1 November 2010 | 3 min read

True blood

Early data suggest that it is possible to identify autism by looking at gene expression in the blood. But it’s going to take more work to prove it.

By Deborah Rudacille
1 November 2010 | 2 min read

Database groups common concepts in autism tests

A searchable new database will greatly ease the task of comparing results from more than 25 diagnostic tests for autism, by creating clusters of the various symptoms measured.

By Deborah Rudacille
27 October 2010 | 4 min read

Explore more from The Transmitter

Cell population in brainstem coordinates cough, new study shows

The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.

By Calli McMurray
6 September 2024 | 5 min read
Capitol building
Spectrum Microphone

In updated U.S. autism bill, Congress calls for funding boost, expanded scope

The current Autism CARES Act sunsets in late September.

By Rachel Zamzow
5 September 2024 | 5 min listen
Illustration of ketamine blocking open ion channels in active NMDA receptors, quieting the cells and disrupting downstream signaling involved in depression.

Ketamine targets lateral habenula, setting off cascade of antidepressant effects

The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.

By Olivia Gieger
4 September 2024 | 6 min read